Gelatinase A-Immunoreactive Protein in Ovarian Lesions— Prognostic Value in Epithelial Ovarian Cancer
- 1 October 1999
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 75 (1), 91-98
- https://doi.org/10.1006/gyno.1999.5533
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Changing views of the role of matrix metalloproteinases in metastasisJNCI Journal of the National Cancer Institute, 1997
- The Family of Matrix MetalloproteinasesaAnnals of the New York Academy of Sciences, 1994
- Expression and activity of MMPS and their regulators in ovarian cancerInternational Journal of Cancer, 1994
- Immunohistochemical localization of matrix metallloproteinase 2 and its specific inhibitor timp‐2 in neoplastic tissues with monclonal antibodiesInternational Journal of Cancer, 1994
- Urokinase plasminogen activator (uPA) and its type 1 inhibitor (PAI-1): Regulators of proteolysis during cancer invasion and prognostic parameters in Breast cancerPublished by Springer Nature ,1994
- Regulation of Lysosomal Endopeptidases in Malignant NeoplasiaPublished by Elsevier ,1994
- Expression of gelatinase A and TIMP-2 mRNAs in desmoplastic fibroblasts in both mammary carcinomas and basal cell carcinomas of the skin.Journal of Clinical Pathology, 1993
- Evaluation of Basement Membrane Components and the 72 kDa Type IV Collagenase in Serous Tumors of the OvaryThe American Journal of Surgical Pathology, 1992
- Modulation of type‐iv collagenase activity and invasive behavior of metastatic human melanoma (A2058) cells in vitro by monoclonal antibodies to type‐iv collagenaseInternational Journal of Cancer, 1990
- Metastatic potential correlates with enzymatic degradation of basement membrane collagenNature, 1980